Raajit K. Rampal

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Raajit K. Rampal

Mar 27, 2025, 07:24 | Drugs

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis - Mount Sinai Department of Medicine

Mount Sinai Department of Medicine shared a post on LinkedIn: "John Mascarenhas, MD, discusses his…

Mar 12, 2025, 10:16 | Science

Ruben Mesa: Pelabresib plus Ruxolitinib for JAKi naive Myelofibrosis

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…

Mar 11, 2025, 07:54 | Science

Raajit Rampal: Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis

Raajit Rampal, an Associate Member at the Memorial Sloan Kettering Cancer Center, recently shared on…

Sep 26, 2024, 15:39 | Insight

Article of the Week, Suggested by the BPDCN International Registry

Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by the…

Jul 9, 2024, 01:37 | Blog

Anand Patel: Our recent article on accelerated/blast-phase MPNs in Blood Advances

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…

All: 5 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023